Sign in

CIK 0001429260

  • Non-accelerated filer
  • Smaller reporting company

Fortress Biotech, Inc.

Sign in to watch
Ticker
FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205157386
Phone
+1 781-652-4500
Business address
1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
Former names
Fortress Biotech, Inc., CORONADO BIOSCIENCES INC

Securities

  • FBIO Common Stock Nasdaq
  • FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4/A Open-market buy Director bought 2,000 shares at $6.95 ($13,900)
  10. 4 Open-market buy Director bought 2,000 shares at $6.95 ($13,900)
  11. 4 Open-market buy Director bought 2,000 shares at $5.66 ($11,320)
  12. 4 Open-market buy Director bought 2,000 shares at $5.67 ($11,340)
  13. 4 Open-market buy Director bought 2,000 shares at $5.66 ($11,320)
  14. 4 Open-market buy Director bought 2,000 shares at $5.40 ($10,800)
  15. 4 Open-market buy Director bought 2,000 shares at $5.40 ($10,800)
  16. 4 Open-market buy Beerman Noah D bought 5,000 shares at $4.99 ($24,960)
  17. 4 Open-market buy President and CEO bought 1,500 shares at an average $5.22 ($7,837)
  18. 4 Open-market buy Director bought 4,000 shares at an average $5.35 ($21,380)
  19. 4 Open-market buy Director bought 2,000 shares at $7.00 ($14,000)
  20. 4 Derivatives Options or other derivatives

Page 14 of 15 · 291 filings